Hellenic Dynamics PLC
Hellenic Dynamics Plc engages in the cultivation and supply of tetrahydrocannabinol (THC) dominant strains of medical cannabis flowers in Europe. It offers medical cannabis product. The company was incorporated in 2007 and is based in London, the United Kingdom.
Hellenic Dynamics PLC (HELD) - Net Assets
Latest net assets as of September 2023: GBX769.39K GBX
Based on the latest financial reports, Hellenic Dynamics PLC (HELD) has net assets worth GBX769.39K GBX as of September 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX1.93 Million) and total liabilities (GBX1.16 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX769.39K |
| % of Total Assets | 39.86% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Hellenic Dynamics PLC - Net Assets Trend (2019–2023)
This chart illustrates how Hellenic Dynamics PLC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Hellenic Dynamics PLC (2019–2023)
The table below shows the annual net assets of Hellenic Dynamics PLC from 2019 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-03-31 | GBX1.68 Million | +269.57% |
| 2021-12-31 | GBX454.96K | +545.17% |
| 2020-12-31 | GBX-102.20K | -738.32% |
| 2019-12-31 | GBX-12.19K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Hellenic Dynamics PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1607923739.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX14.80 Million | 880.23% |
| Other Comprehensive Income | GBX111.73K | 6.64% |
| Other Components | GBX2.97 Million | 176.73% |
| Total Equity | GBX1.68 Million | 100.00% |
Hellenic Dynamics PLC Competitors by Market Cap
The table below lists competitors of Hellenic Dynamics PLC ranked by their market capitalization.
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Hellenic Dynamics PLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2023, total equity changed from 454,960 to 1,681,391, a change of 1,226,431 (269.6%).
- Net loss of 3,890,431 reduced equity.
- Other comprehensive income increased equity by 111,726.
- Other factors increased equity by 5,005,136.
Equity Change Factors (2021 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX-3.89 Million | -231.38% |
| Other Comprehensive Income | GBX111.73K | +6.64% |
| Other Changes | GBX5.01 Million | +297.68% |
| Total Change | GBX- | 269.57% |
Book Value vs Market Value Analysis
This analysis compares Hellenic Dynamics PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 61.89x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | GBX0.00 | GBX0.95 | x |
| 2020-12-31 | GBX0.00 | GBX0.95 | x |
| 2021-12-31 | GBX0.00 | GBX0.95 | x |
| 2023-03-31 | GBX0.02 | GBX0.95 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Hellenic Dynamics PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -231.38%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.94x
- Recent ROE (-231.38%) is below the historical average (-76.54%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | GBX-121.63K |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | GBX-201.63K |
| 2021 | -74.79% | 0.00% | 0.00x | 2.26x | GBX-385.75K |
| 2023 | -231.38% | 0.00% | 0.00x | 1.94x | GBX-4.06 Million |
Industry Comparison
This section compares Hellenic Dynamics PLC's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $4,141,647,912
- Average return on equity (ROE) among peers: 4.87%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Hellenic Dynamics PLC (HELD) | GBX769.39K | 0.00% | 1.51x | $1.10 |
| Animalcare Group Plc (ANCR) | $78.80 Million | -0.10% | 0.40x | $23.67K |
| Alliance Pharma plc (APH) | $16.63 Million | 24.70% | 2.42x | $42.55K |
| Beximco Pharmaceuticals Limited (BXP) | $32.80 Billion | 10.72% | 0.53x | $31.61K |
| Celadon Pharmaceuticals PLC (CEL) | $6.41 Million | -74.61% | 0.03x | $1.12K |
| Eco Animal Health Group Plc (EAH) | $9.77 Million | 20.11% | 0.69x | $8.46K |
| Indivior PLC (INDV) | $209.00 Million | 64.11% | 6.90x | $187.94K |
| N4 Pharma PLC (N4P) | $7.54 Million | 9.68% | 0.74x | $632.90 |
| Provexis plc (PXS) | $7.58 Million | -15.68% | 0.05x | $3.45K |